Pharma stock , Sudarshan Pharma lndustries jumps 6% from lows in the stock market today on this acquisition buzz. It plans ...
Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...
1hon MSN
Tata Power Company shares rose 5% from the day's low on February 20 after announcing a partnership with Amazon Web Services ...
Italian energy group Edison on Thursday forecast a 2025 core profit of between 1.2 billion and 1.4 billion euros ($1.25-1.46 ...
Capitalize on record defense spending with the Global X Defense Tech ETF (SHLD). Diversified holdings, strong growth, and low ...
Elon Musk's DOGE lackeys were behind the firings of agriculture officials needed to address the bird flu pandemic and workers ...
Walmart is set to report earnings for the fourth quarter of fiscal 2025 on Thursday morning, with analysts expecting rising ...
The retailer serves as a barometer for consumer spending due to its scale and commanding market share of the U.S. retail ...
Palantir’s (PLTR) share price plummeted by as much as 12.5% on Wednesday after a report by The Washington Post said that the ...
President Donald Trump plans to impose tariffs of around 25% on auto imports, semiconductor (computer/phone) chips, and pharmaceuticals shipped to the United States.
Whether businesses will pass on tariff costs to customers will depend, in part, on whether the target buyer can afford a steeper price.
Palantir (NASDAQ: PLTR) stock saw big sell-offs in Wednesday's trading. The software specialist's share price ended the daily session down 10.1% and had been off as much as 12.9% earlier in trading.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results